Investigation of toll-like receptor (TLR) 4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drug

BACKGROUND: Proper blocking of toll-like receptor (TLR) activation during disease progression has been reported to have inhibitory effect on the pathogenesis of rheumatoid arthritis (RA). We tested whether the TLR4 inhibitor TAK-242 had potential as a remedy for rheumatoid arthritis. METHODS: The th...

Descripción completa

Detalles Bibliográficos
Autores principales: Samarpita, Snigdha, Kim, Joo Young, Rasool, Mahaboob Khan, Kim, Kyoung Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979396/
https://www.ncbi.nlm.nih.gov/pubmed/31973752
http://dx.doi.org/10.1186/s13075-020-2097-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979396/
https://www.ncbi.nlm.nih.gov/pubmed/31973752
http://dx.doi.org/10.1186/s13075-020-2097-2

Ejemplares similares